Prescription drugs; creating the Insulin Access and Affordability Program; requiring certain financial support and agreement. Effective date. Emergency.

Summary

The bill establishes the Insulin Access and Affordability Program, run by the Oklahoma Department of Health, to provide state‑approved funding to a nonprofit manufacturer developing a fast‑acting biosimilar insulin. The manufacturer must match state funds, agree to sell the insulin at low net cost, and report progress, with repayment required if the product is not delivered.

AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.

Topics

Share